Changes in survival over time for primary brain and other CNS tumors in the United States, 2004–2017 - Top-Institutions - MDSpire

Changes in survival over time for primary brain and other CNS tumors in the United States, 2004–2017

  • By

  • Gino Cioffi

  • Kristin A. Waite

  • Jacob L. Edelson

  • Carol Kruchko

  • Quinn T. Ostrom

  • Jill S. Barnholtz-Sloan

  • October 5, 2022

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Neuro-oncology
    • Neurosurgery
    • Radiation Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Neuro-oncology
    • Neurosurgery
    • Medical Oncology

  • #3

    Dana-Farber Cancer Institute / Brigham and Women’s Hospital
    Dana-Farber Cancer Institute / Brigham and Women’s Hospital

    Boston, MA

    Key Differentiators

    • Neuro-oncology
    • Radiation Oncology
    • Neurosurgery

  • #4

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Neurosurgery
    • Neuro-oncology
    • Radiation Oncology

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Neuro-oncology
    • Neurosurgery
    • Radiation Oncology

Original Source(s)

Changes in survival over time for primary brain and other CNS tumors in the United States, 2004–2017

  • by Gino Cioffi, Kristin A. Waite, Jacob L. Edelson, Carol Kruchko, Quinn T. Ostrom, Jill S. Barnholtz-Sloan

  • October 5, 2022

Related Content

Neurobehavioral outcomes and associated risk factors in pediatric brain tumor survivors

Dana Farber/Boston Children’s Researchers Uncover Distinct Tumor “neighborhoods” with Each Cell Subtype Playing a Specific Role, in Aggressive Childhood Brain Cancer

Their detailed blueprint of tumor cell diversity could guide more precise, targeted treatments for supratentorial ependymomas 

  • by

  • March 12, 2026

  • 3 min
Papillary thyroid carcinoma with brain and lung metastases: a case report